2016
DOI: 10.2174/1573409912666160505113408
|View full text |Cite
|
Sign up to set email alerts
|

Design of Broad-Spectrum Inhibitors of Influenza A Virus M2 Proton Channels: A Molecular Modeling Approach

Abstract: Using the molecular dynamics and molecular docking techniques, we have refined the dynamic dimer-ofdimers structures of the WT, S31N and V27A variants of the M2 proton channel of the influenza A virus, analyzed the inhibitor binding sites, identified a number of potential broad-spectrum inhibitor structures targeting them, and clarified the binding modes and probable mechanisms of action of one promising compound. The proposed approach is also suitable for the design of ligands interacting with other multiple … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…Molecular dynamics simulations, conducted using the procedure described in [ 21 ], indicate ( Figure 2 ), that compound 3 is located in the transmembrane domain of the M2 proton channel of the S31N mutant influenza virus, in the region of amino acids 45–49 of different chains of the M2 tetramer, and does not have direct interactions with the pharmacologically relevant binding site of Rimantadine in the region of amino acid 31 [ 22 ]. This may explain high activity of compound 3 against the Rimantadine-resistant strain of the virus; however additional studies are needed, to establish the mechanism of the antiviral action of 3 .…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Molecular dynamics simulations, conducted using the procedure described in [ 21 ], indicate ( Figure 2 ), that compound 3 is located in the transmembrane domain of the M2 proton channel of the S31N mutant influenza virus, in the region of amino acids 45–49 of different chains of the M2 tetramer, and does not have direct interactions with the pharmacologically relevant binding site of Rimantadine in the region of amino acid 31 [ 22 ]. This may explain high activity of compound 3 against the Rimantadine-resistant strain of the virus; however additional studies are needed, to establish the mechanism of the antiviral action of 3 .…”
Section: Resultsmentioning
confidence: 99%
“…For molecular dynamics simulations, the apo-M2 conductance domain structure (residues 23–60) (the lowest-energy conformer) was obtained from the Protein Data Bank for the S31N mutant influenza virus (PDB: 2KIH). The starting structure of the M2CD complex with compound 3 was obtained by means of molecular docking to the region of amino acids 25–50 (the ligand structure and M2 channel model were prepared as described in [ 21 ]) using the AutoDock Vina 1.1.2 software [ 26 ] (grid box 11.25 Å × 11.25 Å × 11.25 Å, grid center size x = −23.987 Å, y = 4.634 Å, z = −6.149 Å, exhaustiveness = 20), complexes with the best value of scoring function was selected).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…To supplement these shortcomings of influenza vaccines, numerous antiviral compounds have been developed to target and inhibit crucial components of the infectious pathway of the virus. The influenza A M2 proton channel is one of those targets, and the high mutation rate of the influenza virus has led to almost complete resistance against all known M2 inhibitors within four decades of their use. , M2 plays a crucial role in the infection of the host cell during the viral infectivity cycle . Therefore, effective approaches for studying both potential M2 inhibitors and the development of resistance toward inhibitors are obviously of great importance. …”
mentioning
confidence: 99%